Literature DB >> 15717600

Betulonic acid and derivatives, a new group of agents reducing side effects of cytostatics.

I V Sorokina1, T G Tolstikova, N A Zhukova, N I Petrenko, E E Schults, N V Uzenkova, O R Grek, S V Pozdnyakova, G A Tolstikov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15717600     DOI： 10.1007/s10630-005-0004-2

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  3 in total

1.  Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells.

Authors:  Valentina Zuco; Rosanna Supino; Sabina C Righetti; Loredana Cleris; Edoardo Marchesi; Carlo Gambacorti-Passerini; Franca Formelli
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

2.  Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma.

Authors:  M Rieber; M Strasberg Rieber
Journal:  DNA Cell Biol       Date:  1998-05       Impact factor: 3.311

3.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.

Authors:  E Pisha; H Chai; I S Lee; T E Chagwedera; N R Farnsworth; G A Cordell; C W Beecher; H H Fong; A D Kinghorn; D M Brown
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440
  3 in total
  1 in total

Review 1.  Anticancer Potential of Betulonic Acid Derivatives.

Authors:  Adelina Lombrea; Alexandra Denisa Scurtu; Stefana Avram; Ioana Zinuca Pavel; Māris Turks; Jevgeņija Lugiņina; Uldis Peipiņš; Cristina Adriana Dehelean; Codruta Soica; Corina Danciu
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.